Okyo Pharma (OKYO)

Last close As at 16/04/2025

USD1.11

0.00 (−0.45%)

Market capitalisation

USD38m

Okyo Pharma is a clinical-stage biopharmaceutical company developing therapeutic compounds to treat ocular indications including dry eye disease and neuropathic corneal pain.

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Gary Jacob, PhD

    CEO

  • Keeren Shah

    CFO

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free